Effect of conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons

被引:15
作者
Alex, Anitha B. [1 ]
Baucum, Anthony J. [1 ]
Wilcox, Karen S. [1 ]
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Anticonvulsant Drug Dev Program, Salt Lake City, UT 84108 USA
关键词
D O I
10.1152/jn.01325.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Conantokin G (Con G), derived from the venom of Conus geographus, is the most characterized natural peptide antagonist targeted to N-methyl-D-aspartate (NMDA) receptors. Although Con G is known to bind to the glutamate binding site on the NR2 subunit of the receptor, it is unclear whether it can allosterically modulate the function of the receptor through the glycine binding site on the NR1 subunit. This study was designed to evaluate the action of Con G on NMDA receptor mediated spontaneous excitatory postsynaptic currents (sEPSCs) and its modulation by glycine in cultured cortical neurons (13-19 days in vitro) using the whole cell patch-clamp technique. Con G inhibited NMDA receptor-mediated sEPSCs in a concentration-dependent manner. Also, the potency of Con G decreased as a function of time in culture. The inhibition of EPSCs observed after application of Con G in the presence of high (10 mu M) and nominal (no added) concentrations of glycine was not different at 13 days in vitro (DIV). Furthermore, similar results were obtained with experiments on Con G-induced inhibition of NMDA-evoked whole cell currents. These results indicate that glycine concentrations do not have a direct effect on Con G-induced inhibition of NMDA currents. In addition, age dependency in the action of Con G on cortical neurons in vitro suggests that this model system would be useful in examining the effects of different agonists/antagonists on native synaptic NMDA receptors.
引用
收藏
页码:1084 / 1092
页数:9
相关论文
共 46 条
[1]   The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs [J].
Barton, ME ;
White, HS ;
Wilcox, KS .
EPILEPSY RESEARCH, 2004, 59 (01) :13-24
[2]   Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism [J].
Baucum, AJ ;
Rau, KS ;
Riddle, EL ;
Hanson, GR ;
Fleckenstein, AE .
JOURNAL OF NEUROSCIENCE, 2004, 24 (13) :3436-3443
[3]  
Brimecombe JC, 1998, J PHARMACOL EXP THER, V286, P627
[4]  
Danysz W, 1998, PHARMACOL REV, V50, P597
[5]   Studies on neuronal apoptosis in primary forebrain cultures: Neuroprotective/anti-apoptotic action of NR2B NMDA antagonists [J].
Dave, JR ;
Williams, AJ ;
Moffett, JR ;
Koenig, ML ;
Tortella, FC .
NEUROTOXICITY RESEARCH, 2003, 5 (04) :255-+
[6]  
de Armentia ML, 2003, J NEUROSCI, V23, P6876
[7]  
Dingledine R, 1999, PHARMACOL REV, V51, P7
[8]   Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors [J].
Donevan, SD ;
McCabe, RT .
MOLECULAR PHARMACOLOGY, 2000, 58 (03) :614-623
[9]   Deletion of the NR2A subunit prevents developmental changes of NMDA-mEPSCs in cultured mouse cerebellar granule neurones [J].
Fu, ZY ;
Logan, SM ;
Vicini, S .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 563 (03) :867-881
[10]   CONANTOKIN-G SELECTIVELY INHIBITS N-METHYL-D-ASPARTATE-INDUCED CURRENTS IN XENOPUS OOCYTES INJECTED WITH MOUSE-BRAIN MESSENGER-RNA [J].
HAMMERLAND, LG ;
OLIVERA, BM ;
YOSHIKAMI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 226 (03) :239-244